124 related articles for article (PubMed ID: 31082370)
1. Bone marrow-liver-thymus (BLT) immune humanized mice as a model to predict cytokine release syndrome.
Yan H; Semple KM; Gonzaléz CM; Howard KE
Transl Res; 2019 Aug; 210():43-56. PubMed ID: 31082370
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models.
Yan H; Bhagwat B; Sanden D; Willingham A; Tan A; Knapton AD; Weaver JL; Howard KE
Toxicol Appl Pharmacol; 2019 Jun; 372():57-69. PubMed ID: 30914376
[TBL] [Abstract][Full Text] [Related]
3. Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model.
Martin GH; Gonon A; Martin-Jeantet P; Renart-Depontieu F; Biesova Z; Cifuentes A; Mukherjee A; Thisted T; Doerner A; Campbell DO; Bourré L; van der Horst EH; Rezza A; Thiam K
Front Immunol; 2024; 15():1357716. PubMed ID: 38384461
[TBL] [Abstract][Full Text] [Related]
4. BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.
Weaver JL; Zadrozny LM; Gabrielson K; Semple KM; Shea KI; Howard KE
Toxicol Sci; 2019 May; 169(1):194-208. PubMed ID: 30850839
[TBL] [Abstract][Full Text] [Related]
5. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
6. Development of a flow cytometry-based potency assay for prediction of cytokine storms induced by biosimilar monoclonal antibodies.
Madsen NH; Gad M; Larsen J
J Immunol Methods; 2022 Mar; 502():113231. PubMed ID: 35122772
[TBL] [Abstract][Full Text] [Related]
7. A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees.
Hsu DH; Shi JD; Homola M; Rowell TJ; Moran J; Levitt D; Druilhet B; Chinn J; Bullock C; Klingbeil C
Transplantation; 1999 Aug; 68(4):545-54. PubMed ID: 10480415
[TBL] [Abstract][Full Text] [Related]
8. A humanised mouse model of cytokine release: comparison of CD3-specific antibody fragments.
Malcolm SL; Smith EL; Bourne T; Shaw S
J Immunol Methods; 2012 Oct; 384(1-2):33-42. PubMed ID: 22796190
[TBL] [Abstract][Full Text] [Related]
9. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
Cole MS; Anasetti C; Tso JY
J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
11. HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.
Cole MS; Stellrecht KE; Shi JD; Homola M; Hsu DH; Anasetti C; Vasquez M; Tso JY
Transplantation; 1999 Aug; 68(4):563-71. PubMed ID: 10480417
[TBL] [Abstract][Full Text] [Related]
12. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
13. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
[TBL] [Abstract][Full Text] [Related]
14. Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells.
Hu X; Zafar MI; Gao F
Drug Des Devel Ther; 2015; 9():4847-60. PubMed ID: 26346531
[TBL] [Abstract][Full Text] [Related]
15. Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies.
Nouveau L; Buatois V; Cons L; Chatel L; Pontini G; Pleche N; Ferlin WG
Eur J Immunol; 2021 Aug; 51(8):2074-2085. PubMed ID: 33945643
[TBL] [Abstract][Full Text] [Related]
16. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
[TBL] [Abstract][Full Text] [Related]
17. Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.
Smith DJ; Lin LJ; Moon H; Pham AT; Wang X; Liu S; Ji S; Rezek V; Shimizu S; Ruiz M; Lam J; Janzen DM; Memarzadeh S; Kohn DB; Zack JA; Kitchen SG; An DS; Yang L
Stem Cells Dev; 2016 Dec; 25(24):1863-1873. PubMed ID: 27608727
[TBL] [Abstract][Full Text] [Related]
18. Hypogammaglobulinemia in BLT humanized mice--an animal model of primary antibody deficiency.
Martinez-Torres F; Nochi T; Wahl A; Garcia JV; Denton PW
PLoS One; 2014; 9(10):e108663. PubMed ID: 25271886
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study.
Vincenti F; Danovitch GM; Neylan JF; Steiner RW; Everson MP; Gaston RS
Transplantation; 1996 Feb; 61(4):573-7. PubMed ID: 8610383
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells.
Popma SH; Griswold DE; Li L
Int Immunopharmacol; 2005 Jan; 5(1):155-62. PubMed ID: 15589476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
